Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Removal of Intracanal Medicaments by Different Techniques Using Cone Beam Computed Tomography Analysis

NCT07719985 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-08-04
Last updated
2026-10-06

Condition(s) studied

Removal of Intracanal Medication

Investigational drug(s) / intervention(s)

Manual Dynamic AgitationSonic ActivationXP-Endo Finisher Activation

Manual Dynamic Agitation: Manual dynamic agitation was used for the removal of intracanal calcium hydroxide following standardized root canal preparation and irrigation.

Sonic Activation: Sonic activation was used for the removal of intracanal calcium hydroxide following standardized root canal preparation and irrigation.

XP-Endo Finisher Activation: XP-Endo Finisher activation was used for the removal of intracanal calcium hydroxide following standardized root canal preparation and irrigation.

Study summary

the goal of this study is to evaluate the efficency of different activation techniques in removal of intracanal medication using cone beam computed tomography analysis

Eligibility

Sex
ALL
Min age
20 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: 1. Restorable mature non-vital single canal anterior tooth with or without signs of periapical pathosis. 2. Teeth without anatomical variations 3. Medically free patients Exclusion Criteria: 1. Non-restorable tooth 2. Retreatment cases 3. Teeth with root fractures 4. Teeth with root resorption

Primary outcome measure(s)

  • Volume of Remnants of Intracanal Calcium Hydroxide — 1 week after intracanal medicament placement
    The volume of remnants of intracanal calcium hydroxide after removal using the assigned activation technique, measured by cone beam computed tomography (CBCT).

Trial sites (2)

FacilityCityRegionStatus
Tanta University, Faculty of Dentistry Tanta Gharbia Governorate Recruiting
Faculty of Dentistry, Tanta University Tanta Gharbia Governorate Not Yet Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07719985 on ClinicalTrials.gov ↗ ← All trials in Egypt